Zlamy, Manuela <br/><br/>
Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy.  [electronic resource] 

 -  Pediatric transplantation  Sep 2012 
 - E246-50 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1399-3046 
<br/><br/><label>Standard No.: </label>10.1111/j.1399-3046.2011.01585.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies--chemistry<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Atypical Hemolytic Uremic Syndrome<br/>Child<br/>Complement Factor H--genetics<br/>Complement Inactivating Agents--pharmacology<br/>Hemolytic-Uremic Syndrome--complications<br/>Heterozygote<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Transplantation--methods<br/>Male<br/>Meningococcal Infections--immunology<br/>Meningococcal Vaccines--immunology<br/>Mutation<br/>Mycophenolic Acid--analogs & derivatives<br/>Neisseria meningitidis--metabolism<br/>Peritoneal Dialysis<br/>Recurrence<br/>Renal Insufficiency--therapy<br/>Steroids--therapeutic use<br/>Tacrolimus--therapeutic use<br/>Time Factors